Who is sponsoring NCT03721731?

NCT03721731 is sponsored by USGI Medical.

What drugs are being tested in NCT03721731?

Interventions in NCT03721731: Obesity treatment with a Plication device.

What condition does NCT03721731 study?

NCT03721731 studies Treatment of Obesity.

Is NCT03721731 still recruiting?

NCT03721731 is currently completed. Last updated 4 November 2020.

Last reviewed 2020-11-04 · How we verify

NCT03721731

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Post-Market Surveillance Study of Using the g-Cath EZ for Treating Obesity

Completed Last updated 4 November 2020

What this trial tests

trial testing Obesity treatment with a Plication device in Treatment of Obesity in 39 participants. Completed in 21 February 2020.

Timeline

18 September 2018

Primary endpoint
21 February 2020

21 February 2020

Quick facts

Lead sponsor	USGI Medical
Status	Completed
Study type	OBSERVATIONAL
Enrollment	39
Start date	18 September 2018
Primary completion	21 February 2020
Estimated completion	21 February 2020
Sites	2 locations across Spain

Drugs / interventions tested

Obesity treatment with a Plication device

Conditions studied

Treatment of Obesity — all drugs for Treatment of Obesity →

Sponsor

USGI Medical

Who can join

Adults 22 to 60, any sex, with Treatment of Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a multi-center, prospective study evaluating a treatment for obesity.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Prospective Multicenter Study of the Primary Obesity Surgery Endoluminal (POSE 2.0) Procedure for Treatment of Obesity.
Lopez Nava G, Arau RT, Asokkumar R, Maselli DB, et al · · 2023 · cited 28× · PMID 35533995 · DOI 10.1016/j.cgh.2022.04.019

Verify or expand the search:

Other USGI Medical trials

Trials by the same sponsor.

NCT03837691 — A Feasibility Study for the Treatment of Primary Obesity · NA · unknown
NCT02279420 — ESSENTIAL Trial™ Sham Cross-over · NA · completed
NCT01958385 — The USGI Medical ESSENTIAL Study for Weight Loss · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03721731 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by USGI Medical
Last refreshed: 4 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03721731.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing